Status:
RECRUITING
The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty
Lead Sponsor:
Sahlgrenska University Hospital
Collaborating Sponsors:
Vastra Gotaland Region
Conditions:
Hip Osteoarthritis
Muscle Weakness
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of th...
Detailed Description
The use of lateral approach has been empirically associated with increased risk of abductor insufficiency and limping after total hip arthroplasty compared with the posterior approach. However lateral...
Eligibility Criteria
Inclusion
- Primary unilateral osteoarthritis of the hip scheduled for total hip arthroplasty.
- Ability to understand and write swedish.
Exclusion
- Impaired funktion of the contralateral hip or knees causing limping.
- Neuromuscular diseases
- Postoperative leg length discrepancy excceding 1 cm
- Postoperative discrepancy in femoral offset exceeding 25% of the femoral offset of the contralateral hip.
Key Trial Info
Start Date :
May 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
580 Patients enrolled
Trial Details
Trial ID
NCT05216666
Start Date
May 11 2022
End Date
December 1 2028
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Mölndal, Sweden, 431 80